Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (647)	10/31/2002 9:29:18 PM
From: mopgcw	Read Replies (1) \| Respond to of 805

Gabriel Capital Reports 5% Passive Stake In StemCells DOW JONES NEWSWIRES WASHINGTON -- Gabriel Capital Corp., associated with investor J. Ezra Merkin, reported holding a 5% stake in StemCells Inc. (STEM), according to a Schedule 13G filed Thursday with the Securities and Exchange Commission. On Monday, Gabriel Capital beneficially owned 1,291,530 StemCells common shares, according to the filing. A Schedule 13G denotes a passive investment stake in a company. Filers aren't required to provide a reason for any changes in stake and aren't required to detail any transactions. StemCells, a biomedical company, develops and licenses cellular therapy to treat diseases of the central nervous system.